Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001855763-21-000016

Options or other derivatives

  • CEO acquired 23,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-08 Grant or award : show line 1 in the form Stock Options +23,334 56,001 D
Loading xslF345X03/primary_doc.xml…